White label ELPA - ClinicalTrials.eu

A study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.

Recruiting

3 1 1
Investigated drugs:
- Lebrikizumab
Study of inavolisib, ribociclib, and fulvestrant for patients with advanced hormone-receptor-positive, HER2-negative breast cancer.

Recruiting

2 1 1
Investigated drugs:
A study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis

Recruiting

2 1
Investigated diseases:
- Psoriatic arthropathy
Study of guselkumab and dietary changes for patients with recurring or difficult-to-treat pouchitis

Recruiting

3 1 1
Investigated diseases:
- Pouchitis
Investigated drugs:
- Guselkumab
A study to evaluate the safety and effectiveness of KPL-387 in patients with well-controlled recurrent pericarditis

Recruiting

2 1 1
Safety of injecting bupivacaine and dexamethasone into the parotid gland for patients undergoing surgery for a benign parotid tumor

Recruiting

2 1 1 1
Investigated diseases:
- Salivary gland cancer
Investigated drugs:
A study of ABBV-706 and atezolizumab for patients with previously untreated extensive stage small cell lung cancer

Recruiting

2 1 1 1
Investigated diseases:
- Small cell lung cancer
Investigated drugs:
A study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis

Recruiting

2 1
Investigated diseases:
- Colitis ulcerative
Investigated drugs:
- Morf-057
- Mirikizumab
+3
A study to evaluate the safety and effectiveness of AZD0292 in people aged 12 years and older with bronchiectasis and chronic Pseudomonas aeruginosa infection

Recruiting

2 1
Investigated diseases:
- Bronchiectasis
Investigated drugs:
- AZD0292
+2
A study to evaluate the effectiveness and safety of REGN13335 in adults with pulmonary arterial hypertension

Recruiting

2 1
Investigated diseases:
- Pulmonary arterial hypertension
Investigated drugs:
- HUMAN IGG4 KAPPA MONOCLONAL ANTIBODY AGAINST PLATELET-DERIVED GROWTH FACTOR SUBUNIT B
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies